Characterization of dihydrofolate reductase genes from trimethoprim- susceptible and trimethoprim-resistant strains of Enterococcus faecalis

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 1, 1999, Pages 141-147

  Coque, Teresa M ^a,b   Singh, Kavindra V ^a   Weinstock, George M ^a   Murray, Barbara E ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROFOLATE REDUCTASE; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; COLONY FORMATION; DRUG EFFECT; DRUG EFFICACY; ENTEROCOCCUS FAECALIS; ENZYME ANALYSIS; GENE LOCATION; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TANDEM REPEAT;

EID: 0032905226     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.1.141     Document Type: Article

References (52)

1. Adrian, P. V., and K. P. Klugman, 1997. Mutations in the dihydrofolate reductase gene of trimethoprim-resistant isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 41:2406-2413.
2. Amyes, S. G. B., and K. J. Towner. 1990. Trimethoprim resistance: epidemiology and molecular aspects. J. Med. Microbiol. 31:1-19.
3. Appleman, J. R., E. E. Howell, J. Kraut, and R. L. Blakley. 1990. Role of the aspartate 27 of dihydrofolate reductase from Escherichia coli in interconversion of active and inactive conformers and binding of NADPDH. J. Biol. Chem. 265:5579-5584.
4. Bolin, J. T., D. J. Filman, D. A. Mathews, R. C. Hamlin, and J. Kraut. 1982. Crystal structures of Escherichia coli and Lactobacillus casei dihydrofolate reductase refined at 1.7Å. I. General features and binding of methotrexate. J. Biol. Chem. 257:13650-13662.
5. Charpentier, E., and P. Courvalin. 1997. Emergence of a new class of trimethoprim resistance gene dfrD in Listeria monocytogenes BM4293. Antimicrob. Agents Chemother. 41:1134-1136.
6. Chenoweth, C. E., K. A. Robinson, and D. R. Schaberg. 1990. Efficacy of ampicillin versus trimethoprim-sulfamethoxazole in a mouse model of lethal enterococcal peritonitis. Antimicrob. Agents Chemother. 34:1800-1802.
7. Chung, C. T., S. Z. Niemela, and R. H. Miller. 1989. One-step preparation of competent Escherichia coli: transformation and storage of bacterial cells in the same solution. Proc. Natl. Acad. Sci. USA 86:2172-2175.
8. Clewell, D. B. 1990. Movable genetic elements and antibiotic resistance in enterococci. Eur. J. Clin. Microbiol. Infect. Dis. 9:90-102.
9. Crider, S. R., and S. D. Colby. 1985. Susceptibility of enterococci to trimethoprim and trimethoprim-sulfamethoxazole. Antimicrob. Agents Chemother. 27:71-75.
10. Cruz-Rodz, A. L., and M. S. Gilmore. 1990. High efficiency introduction of plasmid DNA into glycine treated Enterococcus faecalis by electroporation. Mol. Gen. Genet. 224:152-154.
11. Dale, G. E., C. Broger, A. D'Arcy, P. G. Hartman, R. DeHoogt, S. Jolidon, I. L. Kompis, A. M., H. Langen, H. Locher, M. G. P. Page, D. Stuber, R. L. Then, B. Wipf, and C. Oefner. 1997. A single amino acid substitution in Staphylococcus aureus dihydrofolate reductase determines trimethoprim resistance. J. Mol. Biol. 266:23-30.
12. Dale, G. E., C. Broger, P. G. Hartman, H. Langen, M. G. P. Page, R. L. Then, and D. Stuber. 1995. Characterization of the gene for the chromosomal dihydrofolate reductase (DHFR) of Staphylococcus epidermidis ATCC 14990: the origin of the trimethoprim resistant S1DHFR from Staphylococcus aureus? J. Bacteriol. 177:2965-2970.
13. Dale, G. E., H. Langen, M. G. P. Page, R. L. Then, and D. Stuber. 1995. Cloning and characterization of a novel, plasmid-encoded trimethoprim-resistant dihydrofolate reductase from Staphylococcus haemolyticus MUR313. Antimicrob. Agents Chemother. 39:1920-1924.
14. Demolis, N., L. Mallet, F. Bussereau, and M. Jacquet. 1995. Improved strategy for large-scale DNA sequencing using DNase I cleavage for generating random subclones. BioTechniques 18:453-457.
15. Ehrhardt Howell, E., P. G. Foster, and L. M. Foster. 1988. Construction of a dihydrofolate reductase-deficient mutant of Escherichia coli by gene replacement. J. Bacteriol. 170:3040-3045.
16. Friesenegger, A., S. Fiedler, L. A. Devriese, and R. Wirth. 1991. Genetic transformation of various species of Enterococcus by electroporation. FEMS Microbiol. Lett. 79:323-328.
17. Frosolono, M., S. L. Hodel-Christian, and B. E. Murray. 1991. Lack of homology of enterococci which have high-level resistance to trimethoprim with the dfrA gene of Staphylococcus aureus. Antimicrob. Agents Chemother. 35:1928-1930.
18. Goodhard, G. L. 1984. In vivo v in vitro susceptibility of enterococcus to trimethoprim-sulfamethoxazole. JAMA 252:2748-2749.
19. Grayson, M. L., C. Thauvin-Eliopoulos, G. M. Eliopoulos, J. D. C. Yao, D. V. DeAngelis, L. Walton, J. L. Woolley, and R. C. Moellering, Jr. 1990 Failure of trimethoprim-sulfamethoxazole therapy in experimental enterococcal endocarditis. Antimicrob. Agents Chemother. 34:1792-1794.
20. Hamilton-Miller, J., and D. Purves. 1986. Enterococci and antifolate antibiotics. Eur. J. Clin. Microbiol. 5:391-394.
21. Hamilton-Miller, J. M. T. 1988. Reversal of activity of trimethoprim against gram-positive cocci by thymidine, thymine and "folates." J. Antimicrob. Chemother. 22:35-39.
22. Hamilton-Miller, J. M. T., and S. Stewart. 1988. Trimethoprim resistance in enterococci: microbiological and biochemical aspects. Microbios. 56:45-55.
23. Hitchins, G. H. 1973. Mechanism of action of trimethoprim-sulfamethoxazole. J. Infect. Dis. 128(Suppl.):433-436.
24. Huovinen, P. 1987. Trimethoprim resistance. Antimicrob. Agents Chemother. 31:1451-1456.
25. Huovinen, P., L. Sundstrom, G. Swedberg, and O. Skold. 1995. Trimethoprim and sulfonamide resistance. Antimicrob. Agents Chemother. 39:279-289.
26. Iwakura, M., M. Kawata, K. Tsuda, and T. Tanaka. 1988. Nucleotide sequence of the thymidylate synthase B and dihydrofolate reductase genes contained in one Bacillus subtilis operon. Gene 64:9-20.
27. Li, X., G. M. Weinstock, and B. E. Murray. 1995. Generation of auxotrophic mutants of Enterococcus faecalis. J. Bacteriol. 177:6866-6873.
28. Locher, H. H., H. Schlunegger, P. G. Hartman, P. Angehrn, and R. L. Then. 1996. Antibacterial activities of epiroprim, a new dihydrofolate reductase inhibitor, alone and in combination with dapsone. Antimicrob. Agents Chemother. 40:1376-1381.
29. Mangan, M. W., E. B. McNamara, E. G. Smyth, and M. J. Storrs. 1997. Molecular genetic analysis of high-level gentamicin resistance in Enterococcus hirae. J. Antimicrob. Chemother. 40:377-382.
30. Mathews, D. A., J. T. Bolin, J. M. Burridge, D. J. Filman, K. W. Volz, B. T. Kaufman, C. R. Beddel, J. N. Champness, D. K. Stammers, and J. Kraut. 1985. Refined crystal structures of Escherichia coli and chicken liver dihydrofolate reductase containing bound trimethoprim. J. Biol. Chem. 260:381-391.
31. Murray, B. E. 1989. Antibiotic treatment of enterococcal infection. Antimicrob. Agents Chemother. 33:1411.
32. Murray, B. E., F. Y. An, and D. B. Clewell. 1988. Plasmids and pheromone response of the β-lactamase producer Streptococcus (Enterococcus) faecalis HH22. Antimicrob. Agents Chemother. 32:547-551.
33. Murray, B. E., K. V. Singh, J. D. Heath, B. R. Sharma, and G. M. Weinstock. 1990. Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites. J. Clin. Microbiol. 28:2059-2063.
34. Murray, B. E., K. V. Singh, S. M. Markowitz, H. A. Lopardo, J. E. Patterson, M. J. Zervos, E. Rubeglio, G. M. Eliopoulos, L. B. Rice, F. W. Goldstein, S. G. Jenkins, G. M. Caputo, R. Nasnass, L. S. Moore, E. S. Wong, and G. Weinstock. 1991. Evidence for clonal spread of a single strain of β-lactamase-producing Enterococcus faecalis to six hospitals in five states. J. Infect. Dis. 163:780-785.
35. Murray, B. E., K. V. Singh, R. P. Ross, J. D. Heath, G. M. Dunny, and G. M. Weinstock. 1993. Generation of restriction map of Enterococcus faecalis OG1 and investigation of growth requirements and regions encoding biosynthetic function. J. Bacteriol. 175:5216-5223.
36. Najjar, A., and B. E. Murray. 1987. Failure to demonstrate a consistent in vitro bactericidal effect of trimethoprim-sulfamethoxazole against enterococci. Antimicrob. Agents Chemother. 31:808-810.
37. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd ed. Approved standard. NCCLS document M7-A3. National Committee for Clinical Laboratory Standards, Wayne, Pa.
38. Pinter, K., V. J. Davisson, and D. V. Santi. 1988. Cloning and expression of the Lactobacillus casei gene. DNA 7:235-241.
39. Rambaldi, M., L. Ambrosone, S. Migliaresi, and A. Rambaldi. 1997. Combination of co-trimoxazole and ciprofloxacin as therapy of a patient with infective endocarditis caused by an enterococcus highly resistant to gentamicin. J. Antimicrob. Chemother. 40:737-738.
40. Rouch, D. A., L. J. Messerotti, L. S. L. Loo, C. A. Jackson, and L. A. Skurray. 1989. Trimethoprim resistance transposon Tn4003 from Staphylococcus aureus encodes genes for a dihydrofolate reductase and thymidylale synthetase flanked by three copies of IS257. Mol. Microbiol. 3:161-175.
41. Rubens, C. E., and L. M. Heggen. 1988. Tn916ΔE: A Tn916 transposon derivative expressing erythromycin resistance. Plasmid 20:137-142.
42. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
43. Shiyuza, H., B. Birren, U.-J. Kim, S. T. Mancino, Y. Slepak, Y. Tachiiri, and M. Simon. 1992. Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector. Proc. Natl. Acad. Sci. USA 89:8794-8797.
44. Teng, F., B. E. Murray, and G. M. Weinstock. 1998. Conjugal transfer of plasmid DNA from Escherichia coli to enterococci: a method to make insertion mutations. Plasmid 39:182-186.
45. Then, R. L. 1982. Mechanisms of resistance to trimethoprim, the sulfonamides, and trimethoprim-sulfamethoxazole. Rev. Infect. Dis. 4:261-269.
46. Tolleson, W. H., F. Ahmed, and R. B. Dunlap. 1987. Cloning of the linked thymidylate synthase and dihydrofolate reductase genes from aminopterin-resistant Lactobacillus casei. Fed. Proc. 46:2073. (Abstract 862.)
47. Trieu-Cuot, P., C. Carlier, C. Poyart-Salmeron, and P. Courvalin. 1991 An integrative vector exploiting the transposition properties of Tn1545 for insertional mutagenesis and cloning of genes from gram-positive bacteria. Gene 106:21-27.
48. Tripodi, M. F., R. Utili, A. Locatelli, P. Rosario, A. Florio, and G. Ruggiero. 1996. Unorthodox antibiotic combinations including ciprofloxacin against high level gentamicin resistant enterococci. J Antimicrob. Chemother. 37: 727-736.
49. Tripodi, M. F., A. Rambaldi, R. Utili, P. Rosario, V. Attanasio, A. Locatelli, L. E. Adinolfi, A. Andreana, A. Florio, and G. Ruggiero. 1995. Resistance to aminoglycosides and other antibiotics among clinical isolates of Enterococcus spp. New Microbiol. 18:319-323.
50. Woodford, N., D. Morrison, B. Cookson, and R. C. George. 1993. Comparison of high-level gentamicin-resistant Enterococcus faecium isolates from different continents. Antimicrob. Agents Chemother. 37:681-684.
51. Xu, Y., L. Jiang, B. E. Murray, and G. M. Weinstock. 1995. Enterococcus faecalis antigens in human infections. J. Bacteriol. 65:4207-4215.
52. Zervos, M. J., and D. S. Schaberg. 1985. Reversal of the in vitro susceptibility of enterococci to trimethoprim-sulfamethoxazole by folinic acid. Antimicrob. Agents Chemother. 28:446-448.